Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Phillips

Showing results (721-730 of 1,132) with videos related to

Pageof 114
Sort By:
AIDS (London, England)|April 2, 2019
Risk factors for antiretroviral therapy (ART) discontinuation in a large multinational trial of early ART initiatorsLoveleen Bansi-Matharu, Gabriela Rodriguez Loria, Stephen R Cole, et al.
Plos One|April 23, 2015
Projected Lifetime Healthcare Costs Associated with HIV InfectionFumiyo Nakagawa, Alec Miners, Colette J Smith, et al.
AIDS (London, England)|March 21, 2003
Viral breakthrough after suppression with highly active antiretroviral therapy: experience from 233 individuals with viral loads of less than 50 copies/ml followed for up to 4 yearsFiona C Lampe, Margaret A Johnson, Marc Lipman, et al.
HIV Medicine|February 20, 2007
Treatment outcomes amongst previously antiretroviral-naïve HIV-infected patients starting lopinavir/ritonavir-containing antiretroviral regimens at the Royal Free HospitalC J Smith, A N Phillips, M S Youle, et al.
AIDS (London, England)|August 2, 2003
Virological rebound after suppression on highly active antiretroviral therapyAmanda Mocroft, Lidia Ruiz, Peter Reiss, et al.
Antiviral Therapy|August 6, 2011
Predictors of having a resistance test following confirmed virological failure of combination antiretroviral therapy: data from EuroSIDAZoe V Fox, Alessandro Cozzi-Lepri, Antonella D'Arminio Monforte, et al.
Lancet (London, England)|November 9, 2000
AIDS across Europe, 1994-98: the EuroSIDA studyA Mocroft, C Katlama, A M Johnson, et al.
JAMA|April 13, 1994
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study GroupJ D Lundgren, A N Phillips, C Pedersen, et al.
The Journal of Infectious Diseases|July 23, 2002
Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell countsVeronica Miller, Andrew N Phillips, Bonaventura Clotet, et al.
AIDS (London, England)|November 4, 2000
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral loadV Miller, C A Sabin, A N Phillips, et al.
Pageof 114

Showing results (721-730 of 1,132) with videos related to

Sort By:
Pageof 114
AIDS (London, England)|April 2, 2019
Risk factors for antiretroviral therapy (ART) discontinuation in a large multinational trial of early ART initiatorsLoveleen Bansi-Matharu, Gabriela Rodriguez Loria, Stephen R Cole, et al.
Plos One|April 23, 2015
Projected Lifetime Healthcare Costs Associated with HIV InfectionFumiyo Nakagawa, Alec Miners, Colette J Smith, et al.
AIDS (London, England)|March 21, 2003
Viral breakthrough after suppression with highly active antiretroviral therapy: experience from 233 individuals with viral loads of less than 50 copies/ml followed for up to 4 yearsFiona C Lampe, Margaret A Johnson, Marc Lipman, et al.
HIV Medicine|February 20, 2007
Treatment outcomes amongst previously antiretroviral-naïve HIV-infected patients starting lopinavir/ritonavir-containing antiretroviral regimens at the Royal Free HospitalC J Smith, A N Phillips, M S Youle, et al.
AIDS (London, England)|August 2, 2003
Virological rebound after suppression on highly active antiretroviral therapyAmanda Mocroft, Lidia Ruiz, Peter Reiss, et al.
Antiviral Therapy|August 6, 2011
Predictors of having a resistance test following confirmed virological failure of combination antiretroviral therapy: data from EuroSIDAZoe V Fox, Alessandro Cozzi-Lepri, Antonella D'Arminio Monforte, et al.
Lancet (London, England)|November 9, 2000
AIDS across Europe, 1994-98: the EuroSIDA studyA Mocroft, C Katlama, A M Johnson, et al.
JAMA|April 13, 1994
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study GroupJ D Lundgren, A N Phillips, C Pedersen, et al.
The Journal of Infectious Diseases|July 23, 2002
Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell countsVeronica Miller, Andrew N Phillips, Bonaventura Clotet, et al.
AIDS (London, England)|November 4, 2000
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral loadV Miller, C A Sabin, A N Phillips, et al.
Pageof 114